(Reuters) - Adamis Pharmaceuticals Corp said on Thursday it received U.S. approval for its emergency epinephrine syringes to treat severe allergic reactions that it intends to be a lower cost rival to Mylan NV's widely used EpiPen, sending its shares up more than 50 percent.
(Reuters Health) - Body-camera footage from Oakland, California police officers shows the officers spoke more respectfully to white drivers than black drivers during routine traffic stops, researchers say.
(Reuters Health) - A small Swedish study of stroke patients finds that activities such as horseback riding and rhythm-and-music therapy can help them feel like they're recovering faster, even if their stroke occurred years earlier.
BOSTON (Reuters) - Lawyers for a Massachusetts pharmacy executive convicted of fraud for his role in a 2012 U.S. meningitis outbreak that killed 64 people asked a judge to order a new trial, charging that prosecutors misbehaved in providing evidence to the jury.
(Reuters Health) - Even though the U.S. Surgeon General has concluded e-cigarette vapor may expose children to nicotine and other harmful chemicals, a new study finds that one in three adults aren’t sure if the devices are dangerous to use around kids.
(Reuters) - A bipartisan group of state attorneys general announced on Thursday that they are jointly investigating the marketing and sales practices of drug companies that manufacture opioid painkillers at the center of a national addiction epidemic.
LONDON, June 15 (Reuters) - Scientists have identified three mutations that, if they occurred at the same time in nature, could turn a strain of bird flu now circulating in China into a potential pandemic virus that could spread among people.
LONDON (Reuters) - A Roche breast cancer drug at the center of a prolonged pricing row in Britain will now be paid for routinely, following a discount deal between the company and the National Health Service, the country's cost watchdog said on Thursday.
Washington (Reuters) - Republican senators trying to repeal Obamacare are forming consensus to keep some of the U.S. healthcare law's taxes they long criticized, in hopes of delaying more drastic funding cuts, particularly to the Medicaid program for the poor and disabled.
LONDON (Reuters) - Google is betting on the potential of European biotech companies to deliver life-changing drugs by investing alongside Swiss company Novartis in a new $300 million fund run by leading life sciences investment firm Medicxi.
(Reuters Health) - “Smart” search programs can ease the process of systematically reviewing new medical research, a key step in getting the best practices from laboratories to doctors' offices, U.S. researchers say.
(Reuters Health) - - Older adults may be more likely to have bleeding stomach ulcers on days when the air has higher levels of nitrogen dioxide, a pollutant produced by car exhaust and power plants, a recent study in Hong Kong suggests.
(Reuters) - BioTime Inc said on Wednesday its Renevia system succeeded in meeting the main goal of a pivotal European trial for facial wasting associated with treatment for HIV, putting it on track to file for European approval this year.